Abstract
Publications in the past year have continued to shed light on the etiology of the excess risk of end-stage renal disease end-stage renal disease among African-Americans. Prospective data now show that even mild elevations in blood pressure are associated with an increased risk of end- stage renal disease. The prevalence of hypertension among African-Americans has been declining, but remains much higher than among White people. Management of hypertension is the best avenue to prevent much of the excess burden of end-stage renal disease, but the relative merits of different agents and levels of blood pressure control are still under study. In addition, individuals with human immunodeficiency virus-related end-stage renal disease represent a small but rapidly growing number off patients that are predominantly African-American. Studies are underway to examine ethnic differences and risk factors for the earlier stages of renal disease as well as genetic mutations for non-Mendelian forms of end-stage renal disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 243-249 |
| Number of pages | 7 |
| Journal | Current Opinion in Nephrology and Hypertension |
| Volume | 6 |
| Issue number | 3 |
| State | Published - 1997 |
Fingerprint
ASJC Scopus subject areas
- Nephrology
- Internal Medicine
Cite this
Further trends in the etiology of end-stage renal disease in African- Americans. / Coresh, Josef; Jaar, Bernard.
In: Current Opinion in Nephrology and Hypertension, Vol. 6, No. 3, 1997, p. 243-249.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Further trends in the etiology of end-stage renal disease in African- Americans
AU - Coresh, Josef
AU - Jaar, Bernard
PY - 1997
Y1 - 1997
N2 - Publications in the past year have continued to shed light on the etiology of the excess risk of end-stage renal disease end-stage renal disease among African-Americans. Prospective data now show that even mild elevations in blood pressure are associated with an increased risk of end- stage renal disease. The prevalence of hypertension among African-Americans has been declining, but remains much higher than among White people. Management of hypertension is the best avenue to prevent much of the excess burden of end-stage renal disease, but the relative merits of different agents and levels of blood pressure control are still under study. In addition, individuals with human immunodeficiency virus-related end-stage renal disease represent a small but rapidly growing number off patients that are predominantly African-American. Studies are underway to examine ethnic differences and risk factors for the earlier stages of renal disease as well as genetic mutations for non-Mendelian forms of end-stage renal disease.
AB - Publications in the past year have continued to shed light on the etiology of the excess risk of end-stage renal disease end-stage renal disease among African-Americans. Prospective data now show that even mild elevations in blood pressure are associated with an increased risk of end- stage renal disease. The prevalence of hypertension among African-Americans has been declining, but remains much higher than among White people. Management of hypertension is the best avenue to prevent much of the excess burden of end-stage renal disease, but the relative merits of different agents and levels of blood pressure control are still under study. In addition, individuals with human immunodeficiency virus-related end-stage renal disease represent a small but rapidly growing number off patients that are predominantly African-American. Studies are underway to examine ethnic differences and risk factors for the earlier stages of renal disease as well as genetic mutations for non-Mendelian forms of end-stage renal disease.
UR - http://www.scopus.com/inward/record.url?scp=0030811618&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030811618&partnerID=8YFLogxK
M3 - Article
C2 - 9263667
AN - SCOPUS:0030811618
VL - 6
SP - 243
EP - 249
JO - Current Opinion in Nephrology and Hypertension
JF - Current Opinion in Nephrology and Hypertension
SN - 1062-4821
IS - 3
ER -